MX9100273A - JOINTLY CONJUGATED VACCINES INCLUDING IMMUNOGENIC PROTEIN, HIV-RELATED PEPTIDES AND ANIONIC PORTIONS - Google Patents

JOINTLY CONJUGATED VACCINES INCLUDING IMMUNOGENIC PROTEIN, HIV-RELATED PEPTIDES AND ANIONIC PORTIONS

Info

Publication number
MX9100273A
MX9100273A MX9100273A MX9100273A MX9100273A MX 9100273 A MX9100273 A MX 9100273A MX 9100273 A MX9100273 A MX 9100273A MX 9100273 A MX9100273 A MX 9100273A MX 9100273 A MX9100273 A MX 9100273A
Authority
MX
Mexico
Prior art keywords
hiv
jointly
related peptides
immunogenic protein
vaccines including
Prior art date
Application number
MX9100273A
Other languages
Spanish (es)
Inventor
William J Leanza
Stephen Marburg
Richard L Tolman
Emilio A Emini
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of MX9100273A publication Critical patent/MX9100273A/en

Links

MX9100273A 1990-07-19 1991-07-18 JOINTLY CONJUGATED VACCINES INCLUDING IMMUNOGENIC PROTEIN, HIV-RELATED PEPTIDES AND ANIONIC PORTIONS MX9100273A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US55533990A 1990-07-19 1990-07-19
US55596690A 1990-07-19 1990-07-19
US71527691A 1991-06-19 1991-06-19

Publications (1)

Publication Number Publication Date
MX9100273A true MX9100273A (en) 1992-02-28

Family

ID=27415698

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9100273A MX9100273A (en) 1990-07-19 1991-07-18 JOINTLY CONJUGATED VACCINES INCLUDING IMMUNOGENIC PROTEIN, HIV-RELATED PEPTIDES AND ANIONIC PORTIONS

Country Status (1)

Country Link
MX (1) MX9100273A (en)

Similar Documents

Publication Publication Date Title
PT100900A (en) PROCESS FOR THE PREPARATION OF CONJUGATED PEPTIDES, AND PEPTIDES SO OBTAINED
EP0467700A3 (en) Coconjugate vaccines comprising immunogenic protein, hiv related peptides, and anionic moieties
DE69003568D1 (en) MEDICINAL PRODUCTS WITH DELAYED RELEASE.
DE69018647D1 (en) DRUG.
DE69115229D1 (en) Drug.
NL195028B (en) Cyclosporin-containing pharmaceutical preparation.
DE68921923D1 (en) Recombinant coccidiosis vaccine.
NL300249I1 (en) Cephalosporins and homologues, preparations and pharmaceutical preparations.
TR27244A (en) Drug delivery device.
DE69101683D1 (en) Recombinant Mareks disease virus.
FR2669346B1 (en) RECOMBINANT POXVIRUS VACCINE AGAINST MEALS.
FI951979A0 (en) Group B Streptococcus conjugate vaccines
IT8821556A0 (en) IMMUNOSTIMULANT PEPTIDES.
ATE193974T1 (en) CHLAMYDIA VACCINES
NZ239281A (en) Antigenic hiv conjugate, vaccine and pharmaceutical composition
ATE253641T1 (en) ANTIGENIC PREPARATIONS
IS4382A (en) A new peptide with an immunogenic effect
DE69527721D1 (en) EMITTER SWITCHED THYRISTOR
FI955605A (en) Arylating drugs
FI943418A (en) Synthetic peptides for rubella vaccine
FR2715304B1 (en) Anti-allergic vaccine.
MX9100273A (en) JOINTLY CONJUGATED VACCINES INCLUDING IMMUNOGENIC PROTEIN, HIV-RELATED PEPTIDES AND ANIONIC PORTIONS
FI923371A (en) EN PHARMACEUTICAL FORMULATION.
ZA915626B (en) Coconjugate vaccines comprising immunogenic protein,hiv related peptides,and anionic moieties
NL300165I1 (en) Babesia vaccine.